Current portal location

Website content

Meetings

Trade instruments to improve access to affordable medicines in developing and least-developed countries

  • Date: 28/11/2013, 10h – 12h30 (Registration closed)
  • Location: Auditorium, Breydel building, 45 Avenue d'Auderghem, 1049 Brussels
  • Registration closes on : 25/11/2013 12:00

Meeting details

  • Date: 28/11/2013, 10h – 12h30 (registration closed)
  • Location: Auditorium, Breydel building, 45 Avenue d'Auderghem, 1049 Brussels
  • Registration closes on : 25/11/2013 12:00

The issue of access to affordable medicines in low-income countries remains highly debated.

For many years the debate has focused on the role of intellectual property in the treatment of the population in developing and least-developed countries. Recent studies, though, are showing that effective access to medicines can be undermined by a number of factors of varying impact.

The purpose of this meeting is to exchange points of view on trade policy instruments that can help improve access to medicines and remove current obstacles for patients in developing countries.

In order to broaden the debate and to the extent that they can constitute trade-related obstacles to access to medicines, the following issues could be addressed in the debate:

  • Government Procurement
  • Competition policy
  • Import tariffs and non-tariff barriers
  • Intellectual Property
  • Research and development funding and complementary models of financing
  • Services and investment including in the area of health
  • Mark-ups in the pharmaceutical supply chain.

Lead Participants

Mr Anders C. Jessen, Head of Unit, Intellectual Property and Public Procurement, Directorate-General for Trade

Mr Pedro Velasco Martins, Deputy Head of Unit, Intellectual Property and Public Procurement, Directorate-General for Trade

Ms Isabelle Fezas Vital, Policy Officer, Market Access, Industry, Energy and Raw Materials, Directorate-General for Trade
 
Ms Helle Aagaard, EU representative MSF Access Campaign, Médecins Sans Frontières

Ms Leïla Bodeux, Essential Services Policy Officer, Oxfam solidarité

Mr Sergio Napolitano, Trade Policy Officer, European Generic Medicines Association


Moderator


Ms Montserrat Gago, Coordinator relations with civil society, Information, Communication and Civil Society Unit, Directorate-General for Trade

Agenda

1. Introduction by the European Commision
2. Presentation of contributions by stakeholders
2. Coffee break
3. Round-table discussion

Further information

EU Trade Access to medicines webpage

We would be grateful if participants could arrive 10/15 minutes in advance. A reception desk will be set up at the entrance of the Breydel building, where you will receive a badge and gain access to the meeting room. Please bring with you the confirmation email received when you registered for the meeting.
 

About travel expense.

Related documents

Organisations that have registered to participate in this meeting.

  • Ms Helle Aagaard, Médecins Sans Frontières
  • Mr Georgios Altintzis, International Trade Union Confederation
  • Mr Brendan BARNES, European Federation of Pharmaceutical Industries and Associations
  • Ms leïla bodeux, Oxfam solidarité
  • Mr Sebastien Gagnon-Messier , Verband der Chemischen Industrie e.V.
  • Mr David Hammerstein, Transatlantic Consumer Dialogue
  • Mrs Dilek Istar Ates, TUSIAD
  • Ms Begoña Iñarra, Africa Europe Faith and Justice Network
  • Mr Marc Maes, Koepel van de Vlaamse Noord-Zuidbeweging - 11.11.11
  • Ms Tessel Mellema, Stichting Health Action International
  • Mr Sergio Napolitano, MEDICINES FOR EUROPE
  • Mr Ioannis Natsis, Transatlantic Consumer Dialogue
  • Mrs Réka Szanto, European Federation of Pharmaceutical Industries and Associations
  • Mrs Mélanie Yammine, European Federation of Pharmaceutical Industries and Associations